Unveiling glycaemic variability patterns linked to the triglyceride‐glucose index in type 2 diabetes: Insights from continuous glucose monitoring

Documenti analoghi

• Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
  di: Rui Sun, et al.
  Pubblicazione: (2025)
• Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
  di: Nathaniel Foo, et al.
  Pubblicazione: (2025)
• Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
  di: Satish K. Garg, et al.
  Pubblicazione: (2024)
• Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
  di: Howard Wolpert, et al.
  Pubblicazione: (2025)
• Long‐term effects of continuous glucose monitoring on glycaemic control: Real‐world evidence in a general adult population with type 1 diabetes in Norway
  di: Bjørn O. Åsvold, et al.
  Pubblicazione: (2025)